Application 210329
- Type
- ANDA
- Sponsor
- JUBILANT GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A210329-001 | TADALAFIL | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-002 | TADALAFIL | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-003 | TADALAFIL | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | |
| A210329-004 | TADALAFIL | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A210329-001 | AB1 |
| A210329-002 | AB1 |
| A210329-003 | AB1 |
| A210329-004 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | caaa826d4ba7… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | TADALAFIL | 2.5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | TADALAFIL | 5MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | TADALAFIL | 10MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | TADALAFIL | 20MG | TABLET / ORAL | AB1 | 2026-05-15 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A210329-001 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-002 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-003 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A210329-004 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-001 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-002 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-003 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A210329-004 | AB1 | 1 | caaa826d4ba7… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-001 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-002 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-003 | AB1 | 1 | a50c72e98297… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A210329-004 | AB1 | 1 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tadalafil | TADALAFIL | Alembic Pharmaceuticals Inc. | abcb2cda-9b3f-45f6-ad5f-c2370b0dd114 | 2025-02-03 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals,Inc. | 0b75f746-866e-3a5b-e063-6294a90a5e02 | 2025-01-03 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals, Inc. | 2ad52dff-9fcd-041f-e063-6394a90afcef | 2025-01-03 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| TADALAFIL | TADALAFIL | NuCare Pharmaceuticals,Inc. | 2a4666e1-4151-f540-e063-6394a90aed0b | 2024-12-27 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | XLCare Pharmaceuticals Inc. | add6afb8-d38c-47a2-8c35-d5940667bb0c | 2024-12-09 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | A-S Medication Solutions | a84c1eab-5934-4e5d-8bb2-0734d6adba6a | 2024-10-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | A-S Medication Solutions | 1580ab76-e229-4b8d-8c7b-82f39fecfebd | 2024-10-24 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | A-S Medication Solutions | b2d163aa-1056-47dd-85aa-297800e6c772 | 2024-10-16 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| tadalafil | TADALAFIL | A-S Medication Solutions | 00cbc656-768d-4995-bb6d-a0d4b32a248c | 2024-10-16 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Advanced Rx of Tennessee, LLC | 248a4705-1403-e94a-e063-6294a90a3544 | 2024-10-15 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Aphena Pharma Solutions - Tennessee, LLC | f2e8821e-04c9-4812-8c9e-39340775cc6e | 2024-09-12 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Alembic Pharmaceuticals Limited | 741102c1-8809-44d4-9098-3dc8c0604764 | 2024-09-05 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| TADALAFIL | TADALAFIL | Solco Healthcare US, LLC | 9489b635-385e-4a05-be02-df39fcafebe3 | 2024-08-27 | Warnings, Adverse reactions | TADALAFIL TADALAFIL |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 85ed0cbc-df84-44df-a9eb-f9587dbc21df | 2024-08-21 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Bryant Ranch Prepack | ff3c7dd3-2dcc-498c-a121-1e2aa62c7a97 | 2024-08-16 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | Zydus Lifesciences Limited | 6c1c3a1f-80a4-417c-8830-5edbb9a0710f | 2024-08-12 | Tadalafil TADALAFIL | |
| Tadalafil | TADALAFIL | Bryant Ranch Prepack | 185a3284-3a4f-44d3-9278-98581d33f95b | 2024-08-08 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| tadalafil | TADALAFIL | Proficient Rx LP | 929e391e-b74b-4ccd-8690-16ffcece7a30 | 2024-08-01 | Warnings, Adverse reactions | tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | 9f83ea2e-8ee8-ab6d-e053-2995a90a1e96 | 2024-06-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
| Tadalafil | TADALAFIL | NuCare Pharmaceuticals,Inc. | a0acad71-8ae3-2827-e053-2995a90a20b3 | 2024-06-20 | Warnings, Adverse reactions | Tadalafil TADALAFIL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.